APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alfentanil

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alfentanil Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchAlfentanil Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Alfentanil Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Alfentanil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alfentanil Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alfentanil Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alfentanil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alfentanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alfentanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alfentanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alfentanil market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alfentanil market include Johnson & Johnson, Novartis, Pfizer, Max Health, JV Healthcare, Horizon Hospital Healthcare, Hameln Pharmaceuticals, CristÁLia and Auden Mckenzie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alfentanil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alfentanil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alfentanil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alfentanil market size, projected growth trends, production technologies, key applications, and end-use industries.

Alfentanil Segment by Company

Johnson & Johnson

Novartis

Pfizer

Max Health

JV Healthcare

Horizon Hospital Healthcare

Hameln Pharmaceuticals

CristÁLia

Auden Mckenzie

Angelini Pharma

Algol Pharma

Akorn

Alfentanil Segment by Type

Intravenous

Subcutaneous

Alfentanil Segment by Application

Perioperative Analgesia

Adjunct to General Anesthesia

Alfentanil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Alfentanil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alfentanil market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alfentanil significant trends, drivers, influence factors in global and regions.

6. To analyze Alfentanil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alfentanil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alfentanil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alfentanil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alfentanil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alfentanil industry.

Chapter 3: Detailed analysis of Alfentanil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alfentanil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alfentanil in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alfentanil Industry Trends Table 2. Alfentanil Industry Drivers Table 3. Alfentanil Industry Opportunities and Challenges Table 4. Alfentanil Industry Restraints Table 5. Global Alfentanil Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alfentanil Revenue Share by Company (2021-2026) Table 7. Global Alfentanil Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Alfentanil Sales Volume Share by Company (2021-2026) Table 9. Global Alfentanil Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alfentanil Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alfentanil Key Company Manufacturing Base & Headquarters Table 12. Global Alfentanil Company, Product Type & Application Table 13. Global Alfentanil Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alfentanil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intravenous Table 18. Significant Companies of Subcutaneous Table 19. Global Alfentanil Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Alfentanil Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Alfentanil Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Alfentanil Sales Volume Share by Type (2021-2026) Table 23. Global Alfentanil Sales Volume Share by Type (2027-2032) Table 24. Global Alfentanil Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alfentanil Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alfentanil Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alfentanil Sales Value Share by Type (2021-2026) Table 28. Global Alfentanil Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Perioperative Analgesia Table 30. Significant Companies of Adjunct to General Anesthesia Table 31. Global Alfentanil Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Alfentanil Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Alfentanil Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Alfentanil Sales Volume Share by Application (2021-2026) Table 35. Global Alfentanil Sales Volume Share by Application (2027-2032) Table 36. Global Alfentanil Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Alfentanil Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Alfentanil Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Alfentanil Sales Value Share by Application (2021-2026) Table 40. Global Alfentanil Sales Value Share by Application (2027-2032) Table 41. Global Alfentanil Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Alfentanil Sales by Region (2021-2026) & (K Units) Table 43. Global Alfentanil Sales Market Share by Region (2021-2026) Table 44. Global Alfentanil Sales by Region (2027-2032) & (K Units) Table 45. Global Alfentanil Sales Market Share by Region (2027-2032) Table 46. Global Alfentanil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Alfentanil Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Alfentanil Sales Value Share by Region (2021-2026) Table 49. Global Alfentanil Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Alfentanil Sales Value Share by Region (2027-2032) Table 51. Global Alfentanil Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Alfentanil Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Alfentanil Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Alfentanil Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Alfentanil Sales by Country (2021-2026) & (K Units) Table 56. Global Alfentanil Sales Market Share by Country (2021-2026) Table 57. Global Alfentanil Sales by Country (2027-2032) & (K Units) Table 58. Global Alfentanil Sales Market Share by Country (2027-2032) Table 59. Global Alfentanil Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Alfentanil Sales Value Market Share by Country (2021-2026) Table 61. Global Alfentanil Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Alfentanil Sales Value Market Share by Country (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Alfentanil Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis Alfentanil Product Portfolio Table 72. Novartis Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Alfentanil Product Portfolio Table 77. Pfizer Recent Development Table 78. Max Health Company Information Table 79. Max Health Business Overview Table 80. Max Health Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Max Health Alfentanil Product Portfolio Table 82. Max Health Recent Development Table 83. JV Healthcare Company Information Table 84. JV Healthcare Business Overview Table 85. JV Healthcare Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. JV Healthcare Alfentanil Product Portfolio Table 87. JV Healthcare Recent Development Table 88. Horizon Hospital Healthcare Company Information Table 89. Horizon Hospital Healthcare Business Overview Table 90. Horizon Hospital Healthcare Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Horizon Hospital Healthcare Alfentanil Product Portfolio Table 92. Horizon Hospital Healthcare Recent Development Table 93. Hameln Pharmaceuticals Company Information Table 94. Hameln Pharmaceuticals Business Overview Table 95. Hameln Pharmaceuticals Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hameln Pharmaceuticals Alfentanil Product Portfolio Table 97. Hameln Pharmaceuticals Recent Development Table 98. CristÁLia Company Information Table 99. CristÁLia Business Overview Table 100. CristÁLia Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CristÁLia Alfentanil Product Portfolio Table 102. CristÁLia Recent Development Table 103. Auden Mckenzie Company Information Table 104. Auden Mckenzie Business Overview Table 105. Auden Mckenzie Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Auden Mckenzie Alfentanil Product Portfolio Table 107. Auden Mckenzie Recent Development Table 108. Angelini Pharma Company Information Table 109. Angelini Pharma Business Overview Table 110. Angelini Pharma Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Angelini Pharma Alfentanil Product Portfolio Table 112. Angelini Pharma Recent Development Table 113. Algol Pharma Company Information Table 114. Algol Pharma Business Overview Table 115. Algol Pharma Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Algol Pharma Alfentanil Product Portfolio Table 117. Algol Pharma Recent Development Table 118. Akorn Company Information Table 119. Akorn Business Overview Table 120. Akorn Alfentanil Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Akorn Alfentanil Product Portfolio Table 122. Akorn Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Alfentanil Distributors List Table 126. Alfentanil Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Alfentanil Product Image Figure 2. Global Alfentanil Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alfentanil Sales (2021-2032) & (K Units) Figure 5. Global Alfentanil Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alfentanil Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intravenous Image Figure 10. Subcutaneous Image Figure 11. Global Alfentanil Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Alfentanil Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alfentanil Sales Volume Share by Type (2021-2032) Figure 14. Global Alfentanil Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alfentanil Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alfentanil Sales Value Share by Type (2021-2032) Figure 17. Perioperative Analgesia Image Figure 18. Adjunct to General Anesthesia Image Figure 19. Global Alfentanil Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Alfentanil Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Alfentanil Sales Volume Share by Application (2021-2032) Figure 22. Global Alfentanil Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Alfentanil Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Alfentanil Sales Value Share by Application (2021-2032) Figure 25. Global Alfentanil Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Alfentanil Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Alfentanil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Alfentanil Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 30. North America Alfentanil Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Alfentanil Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Alfentanil Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 36. South America Alfentanil Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Alfentanil Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Alfentanil Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Alfentanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Alfentanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Alfentanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Alfentanil Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Alfentanil Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous
  • Subcutaneous
Applications
  • Perioperative Analgesia
  • Adjunct to General Anesthesia
Companies covered
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Max Health
  • JV Healthcare
  • Horizon Hospital Healthcare
  • Hameln Pharmaceuticals
  • CristÁLia
  • Auden Mckenzie
  • Angelini Pharma
  • Algol Pharma
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alfentanil Sales Value (2021-2032)
  4. 1.2.2 Global Alfentanil Sales Volume (2021-2032)
  5. 1.2.3 Global Alfentanil Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alfentanil Market Dynamics
  1. 2.1 Alfentanil Industry Trends
  2. 2.2 Alfentanil Industry Drivers
  3. 2.3 Alfentanil Industry Opportunities and Challenges
  4. 2.4 Alfentanil Industry Restraints
3 Alfentanil Market by Company
  1. 3.1 Global Alfentanil Company Revenue Ranking in 2025
  2. 3.2 Global Alfentanil Revenue by Company (2021-2026)
  3. 3.3 Global Alfentanil Sales Volume by Company (2021-2026)
  4. 3.4 Global Alfentanil Average Price by Company (2021-2026)
  5. 3.5 Global Alfentanil Company Ranking (2024-2026)
  6. 3.6 Global Alfentanil Company Manufacturing Base and Headquarters
  7. 3.7 Global Alfentanil Company Product Type and Application
  8. 3.8 Global Alfentanil Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alfentanil Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alfentanil Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alfentanil Market by Type
  1. 4.1 Alfentanil Type Introduction
  2. 4.1.1 Intravenous
  3. 4.1.2 Subcutaneous
  4. 4.2 Global Alfentanil Sales Volume by Type
  5. 4.2.1 Global Alfentanil Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alfentanil Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alfentanil Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alfentanil Sales Value by Type
  9. 4.3.1 Global Alfentanil Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alfentanil Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alfentanil Sales Value Share by Type (2021-2032)
5 Alfentanil Market by Application
  1. 5.1 Alfentanil Application Introduction
  2. 5.1.1 Perioperative Analgesia
  3. 5.1.2 Adjunct to General Anesthesia
  4. 5.2 Global Alfentanil Sales Volume by Application
  5. 5.2.1 Global Alfentanil Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alfentanil Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Alfentanil Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Alfentanil Sales Value by Application
  9. 5.3.1 Global Alfentanil Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alfentanil Sales Value by Application (2021-2032)
  11. 5.3.3 Global Alfentanil Sales Value Share by Application (2021-2032)
6 Alfentanil Regional Sales and Value Analysis
  1. 6.1 Global Alfentanil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alfentanil Sales by Region (2021-2032)
  3. 6.2.1 Global Alfentanil Sales by Region: 2021-2026
  4. 6.2.2 Global Alfentanil Sales by Region (2027-2032)
  5. 6.3 Global Alfentanil Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alfentanil Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alfentanil Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alfentanil Sales Value by Region (2027-2032)
  9. 6.5 Global Alfentanil Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alfentanil Sales Value (2021-2032)
  12. 6.6.2 North America Alfentanil Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alfentanil Sales Value (2021-2032)
  15. 6.7.2 Europe Alfentanil Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alfentanil Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alfentanil Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alfentanil Sales Value (2021-2032)
  21. 6.9.2 South America Alfentanil Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alfentanil Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alfentanil Sales Value Share by Country, 2025 VS 2032
7 Alfentanil Country-level Sales and Value Analysis
  1. 7.1 Global Alfentanil Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alfentanil Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alfentanil Sales by Country (2021-2032)
  4. 7.3.1 Global Alfentanil Sales by Country (2021-2026)
  5. 7.3.2 Global Alfentanil Sales by Country (2027-2032)
  6. 7.4 Global Alfentanil Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alfentanil Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alfentanil Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alfentanil Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alfentanil Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alfentanil Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alfentanil Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alfentanil Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alfentanil Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alfentanil Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alfentanil Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alfentanil Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alfentanil Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alfentanil Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alfentanil Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alfentanil Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alfentanil Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alfentanil Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alfentanil Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alfentanil Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alfentanil Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alfentanil Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alfentanil Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alfentanil Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alfentanil Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alfentanil Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alfentanil Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alfentanil Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alfentanil Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alfentanil Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alfentanil Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alfentanil Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alfentanil Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alfentanil Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alfentanil Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alfentanil Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alfentanil Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alfentanil Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alfentanil Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alfentanil Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alfentanil Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alfentanil Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alfentanil Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alfentanil Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alfentanil Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alfentanil Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alfentanil Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alfentanil Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alfentanil Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alfentanil Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alfentanil Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alfentanil Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alfentanil Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alfentanil Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alfentanil Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alfentanil Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alfentanil Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alfentanil Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alfentanil Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alfentanil Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alfentanil Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alfentanil Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alfentanil Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alfentanil Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alfentanil Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alfentanil Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alfentanil Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alfentanil Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alfentanil Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alfentanil Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alfentanil Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alfentanil Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alfentanil Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alfentanil Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alfentanil Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alfentanil Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alfentanil Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alfentanil Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alfentanil Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alfentanil Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alfentanil Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alfentanil Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alfentanil Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alfentanil Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alfentanil Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alfentanil Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alfentanil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Alfentanil Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Alfentanil Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Alfentanil Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Alfentanil Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Alfentanil Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Alfentanil Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Max Health
  20. 8.4.1 Max Health Company Information
  21. 8.4.2 Max Health Business Overview
  22. 8.4.3 Max Health Alfentanil Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Max Health Alfentanil Product Portfolio
  24. 8.4.5 Max Health Recent Developments
  25. 8.5 JV Healthcare
  26. 8.5.1 JV Healthcare Company Information
  27. 8.5.2 JV Healthcare Business Overview
  28. 8.5.3 JV Healthcare Alfentanil Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JV Healthcare Alfentanil Product Portfolio
  30. 8.5.5 JV Healthcare Recent Developments
  31. 8.6 Horizon Hospital Healthcare
  32. 8.6.1 Horizon Hospital Healthcare Company Information
  33. 8.6.2 Horizon Hospital Healthcare Business Overview
  34. 8.6.3 Horizon Hospital Healthcare Alfentanil Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Horizon Hospital Healthcare Alfentanil Product Portfolio
  36. 8.6.5 Horizon Hospital Healthcare Recent Developments
  37. 8.7 Hameln Pharmaceuticals
  38. 8.7.1 Hameln Pharmaceuticals Company Information
  39. 8.7.2 Hameln Pharmaceuticals Business Overview
  40. 8.7.3 Hameln Pharmaceuticals Alfentanil Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hameln Pharmaceuticals Alfentanil Product Portfolio
  42. 8.7.5 Hameln Pharmaceuticals Recent Developments
  43. 8.8 CristÁLia
  44. 8.8.1 CristÁLia Company Information
  45. 8.8.2 CristÁLia Business Overview
  46. 8.8.3 CristÁLia Alfentanil Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CristÁLia Alfentanil Product Portfolio
  48. 8.8.5 CristÁLia Recent Developments
  49. 8.9 Auden Mckenzie
  50. 8.9.1 Auden Mckenzie Company Information
  51. 8.9.2 Auden Mckenzie Business Overview
  52. 8.9.3 Auden Mckenzie Alfentanil Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Auden Mckenzie Alfentanil Product Portfolio
  54. 8.9.5 Auden Mckenzie Recent Developments
  55. 8.10 Angelini Pharma
  56. 8.10.1 Angelini Pharma Company Information
  57. 8.10.2 Angelini Pharma Business Overview
  58. 8.10.3 Angelini Pharma Alfentanil Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Angelini Pharma Alfentanil Product Portfolio
  60. 8.10.5 Angelini Pharma Recent Developments
  61. 8.11 Algol Pharma
  62. 8.11.1 Algol Pharma Company Information
  63. 8.11.2 Algol Pharma Business Overview
  64. 8.11.3 Algol Pharma Alfentanil Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Algol Pharma Alfentanil Product Portfolio
  66. 8.11.5 Algol Pharma Recent Developments
  67. 8.12 Akorn
  68. 8.12.1 Akorn Company Information
  69. 8.12.2 Akorn Business Overview
  70. 8.12.3 Akorn Alfentanil Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Akorn Alfentanil Product Portfolio
  72. 8.12.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alfentanil Value Chain Analysis
  2. 9.1.1 Alfentanil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alfentanil Sales Mode & Process
  6. 9.2 Alfentanil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alfentanil Distributors
  9. 9.2.3 Alfentanil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst